Načítá se...
Strategies to Overcome Therapeutic Resistance in Renal Cell Carcinoma
Renal cell cancer (RCC) is a prevalent and lethal disease. At time of diagnosis, most patients present with localized disease. For these patients, the standard of care includes nephrectomy with close monitoring thereafter. While many patients will be cured, 5-year recurrence rates range from 30% to...
Uloženo v:
| Vydáno v: | Urol Oncol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5318278/ https://ncbi.nlm.nih.gov/pubmed/28089416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2016.12.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|